LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity

被引:7
|
作者
Qin, Min [1 ]
Peng, Shihong [1 ]
Liu, Ning [1 ]
Hu, Meichun [1 ]
He, Yundong [1 ]
Li, Guoliang [1 ]
Chen, Huang [1 ]
He, Yuan [1 ]
Chen, Ang [1 ]
Wang, Xin [1 ]
Liu, Mingyao [1 ,2 ,3 ]
Chen, Yihua [1 ]
Yi, Zhengfang [1 ]
机构
[1] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China
[2] Texas A&M Univ, Hlth Sci Ctr, Ctr Canc & Stem Cell Biol, Inst Biosci & Technol, Houston, TX USA
[3] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX USA
基金
中国国家自然科学基金;
关键词
TUMOR-GROWTH; MICROTUBULES; APOPTOSIS; TUBULIN; CYCLE; ANGIOGENESIS; CHEMOTHERAPY; TARGET; AGENT;
D O I
10.1124/jpet.115.225912
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Microtubule plays many different essential roles in the process of tumorigenesis in many eukaryotes, and targeting mitotic progression by disturbing microtubule dynamics is used as a common strategy for cancer treatment. Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids, were previously considered to work primarily by increasing or decreasing the cellular microtubule mass. The tubulin/microtubule system, which is an integral component of the cytoskeleton, is a therapeutic target for prostate cancer. In this study, we found a novel synthetic compound, 8-fluoro-N-phenylacetyl-1, 3, 4, 9-tetrahydrob-carboline (LG308), which disrupted the microtubule organization via inhibiting the polymerization of microtubule in PC-3M and LNCaP prostate cancer cell lines. Further study proved that LG308 induced mitotic phase arrest and inhibited G2/M progression significantly in LNCaP and PC-3M cell lines in a dose-dependent manner, and these were associated with the upregulation of cyclin B1 and mitotic marker MPM-2 and the dephosphorylation of cdc2. Besides, the cell proliferation and colony formation of PC-3M and LNCaP cells were effectively inhibited by LG308. Furthermore, LG308 induced apoptosis and cell death in PC-3M and LNCaP cell lines in vitro. In vivo, LG308 dramatically suppressed the growth and metastasis of prostate cancer in both xenograft and orthotopic models. All these data indicate that LG308 is a promising anticancer candidate with antimitotic activity for the treatment of prostate cancer.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 50 条
  • [1] BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo
    Kuo, CC
    Hsieh, HP
    Pan, WY
    Chen, CP
    Lion, JP
    Lee, SJ
    Chang, YL
    Chen, LT
    Chen, CT
    Chang, JY
    CANCER RESEARCH, 2004, 64 (13) : 4621 - 4628
  • [2] Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells
    Tsaur, Igor
    Thomas, Anita
    Monecke, Michelle
    Zugelder, Marion
    Rutz, Jochen
    Grein, Timothy
    Maxeiner, Sebastian
    Xie, Hui
    Chun, Felix K. -H.
    Rothweiler, Florian
    Cinatl, Jindrich, Jr.
    Michaelis, Martin
    Haferkamp, Axel
    Blaheta, Roman A.
    CANCERS, 2022, 14 (13)
  • [3] Lx2-32c,a novel semi-synthetic taxane,exerts antitumor activity against prostate cancer cells in vitro and in vivo
    Guangyao Lv
    Dengjun Sun
    Jingwen Zhang
    Xiaoxia Xie
    Xiaoqiong Wu
    Weishuo Fang
    Jingwei Tian
    Chunhong Yan
    Hongbo Wang
    Fenghua Fu
    ActaPharmaceuticaSinicaB, 2017, 7 (01) : 52 - 58
  • [4] Lx2-32c, a novel semi-synthetic taxane, exerts antitumor activity against prostate cancer cells in vitro and in vivo
    Lv, Guangyao
    Sun, Dengjun
    Zhang, Jingwen
    Xie, Xiaoxia
    Wu, Xiaoqiong
    Fang, Weishuo
    Tian, Jingwei
    Yan, Chunhong
    Wang, Hongbo
    Fu, Fenghua
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (01) : 52 - 58
  • [5] A novel fluorinated stilbene exerts antitumor activity in glioblastoma cells
    Nakabavashi, H.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S779 - S779
  • [6] Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound
    Teraishi, F
    Wu, SH
    Inoue, S
    Zhang, LD
    Davis, JJ
    Guo, W
    Dong, FQ
    Fang, BL
    PROSTATE, 2006, 66 (04): : 430 - 438
  • [7] A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells
    Yan, Jun
    Pang, Yanqing
    Sheng, Jianfeng
    Wang, Yali
    Chen, Jie
    Hu, Jinhui
    Huang, Ling
    Li, Xingshu
    BIOCHEMICAL PHARMACOLOGY, 2015, 97 (01) : 51 - 61
  • [8] Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo
    Carrasco, Esther
    Juan Alvarez, Pablo
    Melguizo, Consolacion
    Prados, Jose
    Alvarez-Manzaneda, Enrique
    Chahboun, Rachid
    Messouri, Ibtissam
    Isabel Vazquez-Vazquez, Maria
    Aranega, Antonia
    Rodriguez-Serrano, Fernando
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 79 : 1 - 12
  • [9] Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells
    Zhao, Xuejiao
    Fang, Yong
    Yang, Yang
    Qin, Yu
    Wu, Peng
    Wang, Ting
    Lai, Huiling
    Meng, Li
    Wang, Daowen
    Zheng, Zhihui
    Lu, Xinhua
    Zhang, Hua
    Gao, Qinglei
    Zhou, Jianfeng
    Ma, Ding
    AUTOPHAGY, 2015, 11 (10) : 1849 - 1863
  • [10] A novel agent exerts antitumor activity in breast cancer cells by targeting mitochondrial complex II
    Wang, Liang
    Zhang, Xiaojing
    Cui, Guozhen
    Chan, Judy Yuet-Wa
    Wang, Li
    Li, Chuwen
    Shan, Luchen
    Xu, Changjiang
    Zhang, Qingwen
    Wang, Yuqiang
    Di, Lijun
    Lee, Simon Ming-Yuen
    ONCOTARGET, 2016, 7 (22) : 32054 - 32064